Article
PAI-1 4G/5G gene polymorphism is associated with angiographic patency in ST-elevation myocardial infarction patients treated with thrombolytic therapy.
Coronary artery disease - 1 Sept 2012
Ozkan Bugra, Cagliyan Caglar E, Elbasan Zafer, Uysal Onur K, Kalkan Gulhan Y, Bozkurt Mehmet, Tekin Kamuran, Bozdogan Sevcan T, Ozalp Ozge, Duran Mustafa, Sahin Durmus Y, Cayli Murat
Abstract excerpt
BACKGROUND: In this study, we examined the relationship between PAI-1 4G/5G polymorphism and patency of the infarct-related artery after thrombolysis in patients with ST-elevation myocardial infarction (STEMI). METHODS: Acute STEMI patients who received thrombolytic therapy within first 12 h were included in our study. The PAI-1 4G/5G promoter region insertion/deletion polymorphism was studied from venous blood...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
